Abstract: The present disclosure pertains to a system for enhancing knowledge consolidation in a subject during sleep. New declarative memories may be better consolidated by presenting sensory stimuli during slow wave sleep that correspond to sensory stimuli presented during prior wakeful learning. The sensory stimuli may include odors, sounds, visual stimulation, touches, tastes, and/or other types of sensory stimuli. The system is configured to provide a prompt sensory stimulus during slow wave sleep that corresponds to a wakeful stimulus provided during wakeful learning. The prompt sensory stimulus may prompt enhanced knowledge consolidation in the subject. In some embodiments, the system may comprise one or more of a slow wave sleep inducer, a sensory stimulator, a sensor, a processor, electronic storage, a user interface, and/or other components.

Abstract: Systems and methods to detect sleep stages of a subject analyze physiological parameters of the subject in combination with a subject's reactions to stimuli of increasing intensity and/or stimuli having different modalities. Stimuli are provided until a predetermined level of probability is reached for the accuracy of an estimation of the sleep stage of the subject.

Abstract: The present inventors have recognized that proper utilization of reconfigurable event driven hardware may achieve optimum power conservation in energy constrained environments including a low power general purpose primary processor and one or more electronic sensors. Aspects of neurobiology and neuroscience, for example, may be utilized to provide such reconfigurable event driven hardware, thereby achieving energy-efficient continuous sensing and signature reporting in conjunction with the one or more electronic sensors while the primary processor enters a low power consumption mode. Such hardware is event driven and operates with extremely low energy requirements.

Abstract: Brain stimulation is used to promote or induce slow-wave activity thought to be associated with the restorative properties of sleep. In a preferred embodiment, transcranial magnetic stimulation is used to provide neural stimulation at a frequency approximating natural slow-wave activity.

Abstract: The invention provides a method of identifying a compound that alters vigilance. The method consists of contacting an invertebrate with a candidate compound, evaluating a vigilance property in the contacted invertebrate, and determining if the candidate compound alters the vigilance property in the contacted invertebrate. A candidate compound that alters the vigilance property in the contacted invertebrate is identified as a compound that alters vigilance. The invention also provides a method of identifying a vigilance enhancing compound that modulates homeostatic regulation or a vigilance diminishing compound that modulates homeostatic regulation. The method consists of contacting an invertebrate with a compound that increases or decreases vigilance, and determining the effect of the compound on a homeostatic regulatory property of vigilance.

Abstract: Brain stimulation is used to promote or induce slow-wave activity thought to be associated with the restorative properties of sleep. In a preferred embodiment, transcranial magnetic stimulation is used to provide neural stimulation at a frequency approximating natural slow-wave activity.

Abstract: Methods of screening for a sleep altering compositions are disclosed as are the identities of various gene products that are involved in sleep function/dysfunction. Also described are methods for modifying the need for sleep and the response to sleep deprivation in subjects.

Abstract: The invention provides a method of identifying a compound that alters vigilance. The method consists of contacting an invertebrate with a candidate compound, evaluating a vigilance property in the contacted invertebrate, and determining if the candidate compound alters the vigilance property in the contacted invertebrate. A candidate compound that alters the vigilance property in the contacted invertebrate is identified as a compound that alters vigilance. The invention also provides a method of identifying a vigilance enhancing compound that modulates homeostatic regulation or a vigilance diminishing compound that modulates homeostatic regulation. The method consists of contacting an invertebrate with a compound that increases or decreases vigilance, and determining the effect of the compound on a homeostatic regulatory property of vigilance.

Abstract: The invention provides screening methods for isolating short sleep, no rebound and sleep deprivation resistant Drosophila mutants. Such mutants are further useful to facilitate identification of sleep-related molecular targets. The invention also encompasses methods for identifying a sleep or wakefulness-promoting compound based on the compound's ability to modulate two pore domain K+ channels.

Abstract: The invention provides a method of identifying a compound that alters vigilance. The method consists of contacting an invertebrate with a candidate compound, evaluating a vigilance property in the contacted invertebrate, and determining if the candidate compound alters the vigilance property in the contacted invertebrate. A candidate compound that alters the vigilance property in the contacted invertebrate is identified as a compound that alters vigilance. The invention also provides a method of identifying a vigilance enhancing compound that modulates homeostatic regulation or a vigilance diminishing compound that modulates homeostatic regulation. The method consists of contacting an invertebrate with a compound that increases or decreases vigilance, and determining the effect of the compound on a homeostatic regulatory property of vigilance.

Abstract: The invention provides novel isolated vigilance nucleic acid molecules, and kits containing two or more isolated vigilance nucleic acid molecules. Methods for diagnosing and treating vigilance disorders, for determining and altering vigilance levels, and for screening for therapeutic compounds useful for treating vigilance disorders and altering vigilance level, are also provided. The diagnostic, therapeutic and screening methods of the invention involve determining expression or activity profiles of vigilance genes.

Abstract: Apparatus which segments visual scenes into discrete objects. The apparatus is able to perceptually group the elements corresponding to a coherent figure, and to segregate them from the background or from another figure. Reentrant signaling among rhythmically active neuronal groups is used to correlate responses along spatially extended contours. The efficacy of the connections is allowed to change on a fast time scale resulting in active reentrant connections which amplify the correlations among neuronal groups and provides the desired segmentation.